Pharma Cos. Must Hand Over Generic Restasis Plans In MDL
A federal judge Wednesday denied three pharmaceutical companies' move to quash subpoenas for information on their plans to make generic substitutes of Allergan's drug Restasis in multidistrict litigation over its alleged...To view the full article, register now.
Already a subscriber? Click here to view full article